DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20180531

Non albicans Candidemia: an emerging menace in neonatal intensive care unit

Chandrashekar G. Shettigar, Sanchita Shettigar

Abstract


Background: Candidemia has become an increasingly major problem in neonatal intensive care unit (NICU) which is associated with high mortality and morbidity. In this study we evaluated the epidemiology of Candidemia in neonates who were admitted to NICU and their in vitro susceptibility to commonly used antifungal drugs.

Methods: This was a retrospective study of candidemia in NICU from October 2014 to September 2017. The isolates were identified as per standard mycological techniques and antifungal susceptibility was determined by disk diffusion method.

Results: Out of 563 blood culture analyzed, 54(9.59%) culture yielded Candida in their blood. The non albicans Candida (NAC) species were the predominant organism for candidemia in neonates, accounting for 35 (64.81%) and the remaining 19 (35.18%) isolates were of C. albicans. Among the NAC species, the maximum isolates were of C. krusei (31.48%) followed by C. glabrata (22.22%). Non albican Candida were more resistant to azole group of antifungal, especially commonly used antifungal like fluconazole (51.43%). Among NAC species, C. glabrata was most resistant and C. tropicalis was least resistant organism. Prematurity <34 weeks, very low birth weight (<1500gm), prolonged use of broad spectrum antibiotic therapy, prolonged use of central venous catheter, mechanical ventilation, parenteral nutrition, prolonged NICU stays and concomitant bacterial sepsis were significantly associated with Candida infection in blood stream. NAC species were also associated with high mortality rate.

Conclusions: Increased incidences of candidemia along with emergence of NAC species have become an important health care issue. Therefore, knowledge of local epidemiological data on candidemia is essential which will guide on therapeutic decision making. 


Keywords


Antifungal, Candidemia, Neonates, Non albican candida

Full Text:

PDF

References


Benjamin DK, Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84-92.

Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J. 2005;24:601-4.

Koppad B, Prakash KP. Neonatal candidiasis: clinical spectrum and epidemiology in a tertiary care centre. Int J Contemp Pediatr. 2017;4:438-41.

Femitha P, Rojo Joy, Adhisivam B, Prasad K, Gane BD, Singh R. Candidemia in neonatal ICU- experience from a tertiary care hospital. Curr Pediatr Res. 2013;17 (1):44-8.

Fu J, Ding Y, Wei B, Wang L, Xu S, Qin P, et al. Epidemiology of Candida albicans and non C. albicans of neonatal candidemia at a tertiary care hospital in western China. BMC Infect Dis. 2017;17:329.

Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of non-albicans candida species in neonatal candidemia. N Am J Med Sci 2013;5(9):541-5.

Nazir A. Non-albicans Candida in Neonatal Septicemia: An emerging clinical entity. Int J Biomed Res. 2016;7(2):47-50.

Choi HK, Jeong SJ, Lee HS, Chin BS, Choi SH, Han SH, et al. Blood Stream infections by Candida glabrata and Candida krusei: a single-center experience. Korean J Intern Med. 2009;24:263-9.

Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of yeasts; Approved guidelines. CLSI document M44-A2. 2nd ed. Wayne: Clinical and Laboratory Standards Institute; 2009.

Sardana V, Pandey A, Madan M, Goel SP, Asthana AK. Neonatal candidemia: A changing trend. Indian J Pathol Microbiol. 2012;55:132-3.

Srinivas Rao MS, Surendranath M, Sandeepthi M. Prevalence of neonatal candidemia in a tertiary care institution in Hyderabad, South India. Int J Res Med Sci. 2014;2:1016-9.

Caggiano G, Lovero G, Giglio O De, Barbuti G, Montagna O, Laforgia N, et al. Candidemia in the neonatal intensive care unit: a retrospective, observational survey and analysis of literature data. Bio Med Res Int. 2017;2017:Article ID 7901763.

Lovero G, Giglio O De, Montagan O, Diella G, Divenuto F, Lopezzo M, et al. Epidemiology of candidemia in neonatal intensive care unit: a persistent public health problem. Ann Ig. 2016;28:282-7.

Basu S, Kumar R, Tilak R, Kumar A. Candida blood stream infection in neonates: experience from a tertiary care teaching hospital of Central India. Indian Pediatr. 2017;54:556-9.

Juyal D, Adekhandi S, Negi V, Sharma N. An outbreak of neonatal Candidemia due to non-albicans Candida species in a resource constrained setting of Uttarakhand State, India. J Clin Neonatol. 2013;2:183-6.

Wadile RG, Bhate VM. Study of clinical spectrum and risk factors of neonatal candidemia. Indian J Pathol Microbiol. 2015;58:472-4.

Avila-Aguero ML, Canas-Coto A, Ulloa-Gutierrez R, Caro MA, Alfaro B, Paris MM. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica. Int J Infect Dis. 2005;9(2):90-5.

Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012;136:997-1003.

Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172-7.